To Order: patrick@cotinis.com
LATS1 antibody |
|||
| 70R-18222 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal LATS1 antibody |
|||
LATS1 antibody |
|||
| 70R-51351 | Fitzgerald | 100 ul | EUR 292.8 |
|
Description: Purified Polyclonal LATS1 antibody |
|||
LATS1 antibody |
|||
| 70R-5683 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal LATS1 antibody |
|||
LATS1 Antibody |
|||
| 36187-100ul | SAB | 100ul | EUR 302.4 |
lats1 Antibody |
|||
| ABD7517 | Lifescience Market | 100 ug | EUR 525.6 |
LATS1 Antibody |
|||
| 1-CSB-PA830665 | Cusabio |
|
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
|||
LATS1 Antibody |
|||
| 1-CSB-PA012769GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
LATS1 Antibody |
|||
| 1-CSB-PA012769LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF, IP; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:500, IP:1:200-1:2000 |
|||
LATS1 Antibody |
|||
| F50049-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
LATS1 Antibody |
|||
| F50049-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
LATS1 Antibody |
|||
| RQ4584 | NSJ Bioreagents | 100ug | EUR 356.15 |
|
Description: Serine/threonine-protein kinase LATS1 is an enzyme that in humans is encoded by the LATS1 gene. It is mapped to 6q25.1. The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
LATS1/2 Conjugated Antibody |
|||
| C33232 | SAB | 100ul | EUR 476.4 |
LATS1/2 Polyclonal Antibody |
|||
| ABP51705-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041 |
|||
LATS1/2 Polyclonal Antibody |
|||
| ABP51705-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041 |
|||
LATS1/2 Polyclonal Antibody |
|||
| ABP51705-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041 |
|||
LATS1/2 Polyclonal Antibody |
|||
| ABP59096-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein |
|||
LATS1/2 Polyclonal Antibody |
|||
| ABP59096-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein |
|||
LATS1/2 Polyclonal Antibody |
|||
| ABP59096-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein |
|||
LATS1/2 Polyclonal Antibody |
|||
| ES2704-100ul | ELK Biotech | 100ul | EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against LATS1/2 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
LATS1/2 Polyclonal Antibody |
|||
| ES2704-50ul | ELK Biotech | 50ul | EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against LATS1/2 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
LATS1 / LATS2 Antibody |
|||
| 20-abx325262 | Abbexa |
|
|
LATS1 / LATS2 Antibody |
|||
| abx331369-100ul | Abbexa | 100 ul | EUR 510 |
LATS1/LATS2 Antibody |
|||
| CSB-PA069135- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
LATS1/LATS2 Antibody |
|||
| CSB-PA069135-100ul | Cusabio | 100ul | EUR 379.2 |
|
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
LATS1/LATS2 Antibody |
|||
| 1-CSB-PA003141 | Cusabio |
|
|
|
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000 |
|||
LATS1 / 2 (pS909 / 872) Antibody |
|||
| abx216529-100ug | Abbexa | 100 ug | EUR 526.8 |
anti- LATS1 antibody |
|||
| FNab04708 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against LATS1 |
|||
LATS1/LATS2 Polyclonal Antibody |
|||
| 30393-100ul | SAB | 100ul | EUR 302.4 |
LATS1/LATS2 Polyclonal Antibody |
|||
| 30393-50ul | SAB | 50ul | EUR 224.4 |
LATS1 Conjugated Antibody |
|||
| C36187 | SAB | 100ul | EUR 476.4 |
LATS1/2 (Phospho- Ser909/872) Antibody |
|||
| ABF8163 | Lifescience Market | 100 ug | EUR 525.6 |
Anti-LATS1/LATS2 antibody |
|||
| STJ11100242 | St John's Laboratory | 100 µl | EUR 332.4 |
LATS1/2 (Phospho-Ser909/872) Antibody |
|||
| 12514-100ul | SAB | 100ul | EUR 302.4 |
LATS1/2 (Phospho-Ser909/872) Antibody |
|||
| 12514-50ul | SAB | 50ul | EUR 224.4 |
LATS1 Antibody, HRP conjugated |
|||
| 1-CSB-PA012769LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
LATS1/2 (Phospho-Thr1079/1041) Antibody |
|||
| 11736-100ul | SAB | 100ul | EUR 302.4 |
LATS1/2 (Phospho-Thr1079/1041) Antibody |
|||
| 11736-50ul | SAB | 50ul | EUR 224.4 |
LATS1 / 2 (Phospho-Thr1079 / 1041) Antibody |
|||
| 20-abx012605 | Abbexa |
|
|
LATS1 Antibody, FITC conjugated |
|||
| 1-CSB-PA012769LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
LATS1 / LATS2 (pT1079 / 1041) Antibody |
|||
| 20-abx325183 | Abbexa |
|
|
LATS1 / LATS2 (pT1079 / 1041) Antibody |
|||
| abx332955-100ul | Abbexa | 100 ul | EUR 560.4 |
LATS1 Antibody, Biotin conjugated |
|||
| 1-CSB-PA012769LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
LATS1/LATS2 Polyclonal Conjugated Antibody |
|||
| C30393 | SAB | 100ul | EUR 476.4 |
Phospho- LATS1 (Thr1079) Antibody |
|||
| ABF3638 | Lifescience Market | 100 ug | EUR 525.6 |
LATS1 (Phospho-Ser909) Antibody |
|||
| 13033-100ul | SAB | 100ul | EUR 302.4 |
LATS1 (Phospho-Ser909) Antibody |
|||
| 13033-50ul | SAB | 50ul | EUR 224.4 |
LATS1 (Phospho-Tyr283) Antibody |
|||
| 13034-100ul | SAB | 100ul | EUR 302.4 |
LATS1 (Phospho-Tyr283) Antibody |
|||
| 13034-50ul | SAB | 50ul | EUR 224.4 |
LATS1 (Phospho-Thr1079) Antibody |
|||
| 13032-100ul | SAB | 100ul | EUR 302.4 |
LATS1 (Phospho-Thr1079) Antibody |
|||
| 13032-50ul | SAB | 50ul | EUR 224.4 |
LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
| ABP56962-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of LATS1/2 phospho Thr1079/1041) from Human, Mouse. This LATS1/2 phospho Thr1079/1041) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the phosphorylation site of T1079/1041 |
|||
LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
| ABP56962-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of LATS1/2 phospho Thr1079/1041) from Human, Mouse. This LATS1/2 phospho Thr1079/1041) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the phosphorylation site of T1079/1041 |
|||
LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
| ABP56962-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of LATS1/2 phospho Thr1079/1041) from Human, Mouse. This LATS1/2 phospho Thr1079/1041) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the phosphorylation site of T1079/1041 |
|||
LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
| ES7961-100ul | ELK Biotech | 100ul | EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against LATS1/2 (phospho Thr1079/1041) from Human/Mouse. This antibody is tested and validated for IHC, WB, ELISA |
|||
LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
| ES7961-50ul | ELK Biotech | 50ul | EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against LATS1/2 (phospho Thr1079/1041) from Human/Mouse. This antibody is tested and validated for IHC, WB, ELISA |
|||
LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody |
|||
| ABP59095-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein |
|||
LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody |
|||
| ABP59095-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein |
|||
LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody |
|||
| ABP59095-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D | Stressmarq | 0.1ml | EUR 424.8 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is unconjugated. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-A390 | Stressmarq | 0.1ml | EUR 481.2 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 390. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-A488 | Stressmarq | 0.1ml | EUR 480 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 488. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-A565 | Stressmarq | 0.1ml | EUR 480 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 565. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-A594 | Stressmarq | 0.1ml | EUR 480 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 594. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-A633 | Stressmarq | 0.1ml | EUR 480 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 633. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-A655 | Stressmarq | 0.1ml | EUR 480 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 655. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-A680 | Stressmarq | 0.1ml | EUR 480 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 680. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-A700 | Stressmarq | 0.1ml | EUR 480 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 700. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-ALP | Stressmarq | 0.1ml | EUR 472.8 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Alkaline Phosphatase. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-APC | Stressmarq | 0.1ml | EUR 478.8 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to APC . |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-APCCY7 | Stressmarq | 0.1ml | EUR 565.2 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to APC/Cy7. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-BI | Stressmarq | 0.1ml | EUR 475.2 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Biotin. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-DY350 | Stressmarq | 0.1ml | EUR 570 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 350. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-DY405 | Stressmarq | 0.1ml | EUR 542.4 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 405. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-DY488 | Stressmarq | 0.1ml | EUR 518.4 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 488. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-DY594 | Stressmarq | 0.1ml | EUR 523.2 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 594. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-DY633 | Stressmarq | 0.1ml | EUR 511.2 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 633. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-FITC | Stressmarq | 0.1ml | EUR 470.4 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to FITC. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-HRP | Stressmarq | 0.1ml | EUR 465.6 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to HRP. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-P594 | Stressmarq | 0.1ml | EUR 488.4 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to PE/ATTO 594. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-PCP | Stressmarq | 0.1ml | EUR 478.8 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to PerCP. |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-RPE | Stressmarq | 0.1ml | EUR 476.4 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to RPE . |
|||
Antibody for Human LATS1 (pSer909) |
|||
| SPC-1005D-STR | Stressmarq | 0.1ml | EUR 477.6 |
|
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Streptavidin. |
|||
LATS1 (Phospho-Ser909) Conjugated Antibody |
|||
| C13033 | SAB | 100ul | EUR 476.4 |
LATS1 (Phospho-Tyr283) Conjugated Antibody |
|||
| C13034 | SAB | 100ul | EUR 476.4 |
LATS1 (Phospho-Thr1079) Conjugated Antibody |
|||
| C13032 | SAB | 100ul | EUR 476.4 |
Phospho-LATS1/LATS2 (T1079/1041) Antibody |
|||
| 1-CSB-PA070231 | Cusabio |
|
|
|
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (T1079/1041). Recognizes Phospho-LATS1/LATS2 (T1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/20000 |
|||
LATS1/2 (Phospho-Ser909/872) Polyclonal Conjugated Antibody |
|||
| C12514 | SAB | 100ul | EUR 476.4 |
Phospho-LATS1/LATS2 (Thr1079/1041) Antibody |
|||
| CSB-PA905508- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (Thr1079/1041). Recognizes Phospho-LATS1/LATS2 (Thr1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
Phospho-LATS1/LATS2 (Thr1079/1041) Antibody |
|||
| CSB-PA905508-100ul | Cusabio | 100ul | EUR 434.4 |
|
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (Thr1079/1041). Recognizes Phospho-LATS1/LATS2 (Thr1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
LATS1/2 (Phospho-Thr1079/1041) Polyclonal Conjugated Antibody |
|||
| C11736 | SAB | 100ul | EUR 476.4 |
Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
| 20-abx312862 | Abbexa |
|
|
Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
| abx234708-100ug | Abbexa | 100 ug | EUR 577.2 |
Large Tumor Suppressor Kinase 1 (lats1) Antibody |
|||
| abx216530-100ug | Abbexa | 100 ug | EUR 526.8 |
Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
| 20-abx210537 | Abbexa |
|
|
Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
| 20-abx113445 | Abbexa |
|
|
Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
| abx033135-400ul | Abbexa | 400 ul | EUR 627.6 |
Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
| abx033135-80l | Abbexa | 80 µl | EUR 343.2 |
Large Tumor Suppressor Kinase 1 (LATS1) Antibody |
|||
| 20-abx007804 | Abbexa |
|
|
Large Tumor Suppressor Kinase 1 (LATS1) Antibody (HRP) |
|||
| 20-abx312863 | Abbexa |
|
|
Large Tumor Suppressor Kinase 1 (LATS1) Antibody (FITC) |
|||
| 20-abx312864 | Abbexa |
|
|
Large Tumor Suppressor Kinase 1 (LATS1) Antibody (Biotin) |
|||
| 20-abx312865 | Abbexa |
|
|
LATS1 / 2 Blocking Peptide |
|||
| 20-abx061790 | Abbexa |
|
|
lats1/2 Blocking Peptide |
|||
| DF7517-BP | Affbiotech | 1mg | EUR 234 |
Anti-phospho-LATS1-S909/LATS2-S872 antibody |
|||
| STJ11101017 | St John's Laboratory | 50 µl | EUR 471.6 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
Anti-phospho-LATS1-S909/LATS2-S872 antibody |
|||
| STJ11101039 | St John's Laboratory | 100 µl | EUR 471.6 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
Anti-phospho-LATS1-T1079/LATS2-T1041 antibody |
|||
| STJ11101018 | St John's Laboratory | 50 µl | EUR 471.6 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
Anti-phospho-LATS1-T1079/LATS2-T1041 antibody |
|||
| STJ11101047 | St John's Laboratory | 100 µl | EUR 471.6 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
LATS1 siRNA |
|||
| 20-abx922294 | Abbexa |
|
|
LATS1 siRNA |
|||
| 20-abx922295 | Abbexa |
|
|
LATS1/LATS2 Rabbit pAb |
|||
| A18286-100ul | Abclonal | 100 ul | EUR 369.6 |
LATS1/LATS2 Rabbit pAb |
|||
| A18286-200ul | Abclonal | 200 ul | EUR 550.8 |
LATS1/LATS2 Rabbit pAb |
|||
| A18286-20ul | Abclonal | 20 ul | EUR 219.6 |
LATS1/LATS2 Rabbit pAb |
|||
| A18286-50ul | Abclonal | 50 ul | EUR 267.6 |
LATS1, GST-Tag |
|||
| 79499 | BPS Bioscience | 10 µg | EUR 410 |
|
Description: Human LATS1 protein with N terminal GST-Tag, GenBank Accession No. NM_004690, a.a 589-end, expressed in an Sf9 expression system. MW = 95 kDa. |
|||
LATS1 Rabbit pAb |
|||
| A17992-100ul | Abclonal | 100 ul | EUR 369.6 |
LATS1 Rabbit pAb |
|||
| A17992-200ul | Abclonal | 200 ul | EUR 550.8 |
LATS1 Rabbit pAb |
|||
| A17992-20ul | Abclonal | 20 ul | EUR 219.6 |
LATS1 Rabbit pAb |
|||
| A17992-50ul | Abclonal | 50 ul | EUR 267.6 |
LATS1 Rabbit pAb |
|||
| A7159-100ul | Abclonal | 100 ul | EUR 460.8 |
LATS1 Rabbit pAb |
|||
| A7159-200ul | Abclonal | 200 ul | Ask for price |
LATS1 Rabbit pAb |
|||
| A7159-20ul | Abclonal | 20 ul | Ask for price |
LATS1 Rabbit pAb |
|||
| A7159-50ul | Abclonal | 50 ul | EUR 318 |
Human Serine/threonine- protein kinase LATS1, LATS1 ELISA KIT |
|||
| ELI-36986h | Lifescience Market | 96 Tests | EUR 988.8 |
Mouse Serine/threonine- protein kinase LATS1, Lats1 ELISA KIT |
|||
| ELI-42693m | Lifescience Market | 96 Tests | EUR 1038 |
Human LATS1(Serine/threonine-protein kinase LATS1) ELISA Kit |
|||
| EH9736 | FN Test | 96T | EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
|||
LATS1 cloning plasmid |
|||
| CSB-CL012769HU1-10ug | Cusabio | 10ug | EUR 279.6 |
|
Description: A cloning plasmid for the LATS1 gene. |
|||
LATS1 cloning plasmid |
|||
| CSB-CL012769HU2-10ug | Cusabio | 10ug | EUR 829.2 |
|
Description: A cloning plasmid for the LATS1 gene. |
|||
LATS1 Blocking Peptide |
|||
| AF7669-BP | Affbiotech | 1mg | EUR 234 |
LATS1 Blocking Peptide |
|||
| AF7670-BP | Affbiotech | 1mg | EUR 234 |
LATS1 Blocking Peptide |
|||
| AF7671-BP | Affbiotech | 1mg | EUR 234 |
LATS1 Blocking Peptide |
|||
| 20-abx064226 | Abbexa |
|
|
LATS1 Blocking Peptide |
|||
| 33R-4095 | Fitzgerald | 100 ug | EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LATS1 antibody, catalog no. 70R-5683 |
|||
LATS1 ELISA KIT|Human |
|||
| EF010629 | Lifescience Market | 96 Tests | EUR 826.8 |
Human LATS1 shRNA Plasmid |
|||
| 20-abx956022 | Abbexa |
|
|
Mouse LATS1 shRNA Plasmid |
|||
| 20-abx971282 | Abbexa |
|
|
LATS1 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K1198203 | ABM | 1.0 ug DNA | EUR 184.8 |
Lats1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K3825503 | ABM | 1.0 ug DNA | EUR 184.8 |
LATS1 ORF Vector (Human) (pORF) |
|||
| ORF005858 | ABM | 1.0 ug DNA | EUR 114 |
LATS1 ORF Vector (Human) (pORF) |
|||
| ORF005859 | ABM | 1.0 ug DNA | EUR 114 |
Lats1 ORF Vector (Mouse) (pORF) |
|||
| ORF048977 | ABM | 1.0 ug DNA | EUR 607.2 |
LATS1 ELISA Kit (Human) (OKEH07987) |
|||
| OKEH07987 | Aviva Systems Biology | 96 Wells | EUR 1075.2 |
|
Description: Description of target: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.078ng/mL |
|||
Lats1 3'UTR GFP Stable Cell Line |
|||
| TU160919 | ABM | 1.0 ml | Ask for price |
LATS1 3'UTR GFP Stable Cell Line |
|||
| TU062287 | ABM | 1.0 ml | EUR 2799.6 |
LATS1 sgRNA CRISPR Lentivector set (Human) |
|||
| K1198201 | ABM | 3 x 1.0 ug | EUR 406.8 |
Lats1 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3825501 | ABM | 3 x 1.0 ug | EUR 406.8 |
LATS1 Protein Vector (Human) (pPM-C-HA) |
|||
| PV023431 | ABM | 500 ng | EUR 394.8 |
LATS1 Protein Vector (Human) (pPM-C-HA) |
|||
| PV023435 | ABM | 500 ng | EUR 394.8 |
LATS1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV195908 | ABM | 500 ng | EUR 1278 |
LATS1 Protein Vector (Human) (pPB-C-His) |
|||
| PV023429 | ABM | 500 ng | EUR 394.8 |
LATS1 Protein Vector (Human) (pPB-N-His) |
|||
| PV023430 | ABM | 500 ng | EUR 394.8 |
LATS1 Protein Vector (Human) (pPM-C-His) |
|||
| PV023432 | ABM | 500 ng | EUR 394.8 |
LATS1 Protein Vector (Human) (pPB-C-His) |
|||
| PV023433 | ABM | 500 ng | EUR 394.8 |
LATS1 Protein Vector (Human) (pPB-N-His) |
|||
| PV023434 | ABM | 500 ng | EUR 394.8 |
LATS1 Protein Vector (Human) (pPM-C-His) |
|||
| PV023436 | ABM | 500 ng | EUR 394.8 |
LATS1 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV195906 | ABM | 500 ng | EUR 1278 |